- Home
- TLSA vs ANVS Comparison
TLSA vs ANVS Comparison
Compare TLSA & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- ANVS
- Stock Information
- Founded
- TLSA 2013
- ANVS 2008
- Country
- TLSA United Kingdom
- ANVS United States
- Employees
- TLSA N/A
- ANVS N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- TLSA Health Care
- ANVS Health Care
- Exchange
- TLSA Nasdaq
- ANVS Nasdaq
- Market Cap
- TLSA 87.8M
- ANVS 110.4M
- IPO Year
- TLSA 2000
- ANVS 2020
- Fundamental
- Price
- TLSA $1.20
- ANVS $9.64
- Analyst Decision
- TLSA
- ANVS Strong Buy
- Analyst Count
- TLSA 0
- ANVS 6
- Target Price
- TLSA N/A
- ANVS $29.67
- AVG Volume (30 Days)
- TLSA 145.8K
- ANVS 341.4K
- Earning Date
- TLSA 05-10-2024
- ANVS 11-06-2024
- Dividend Yield
- TLSA N/A
- ANVS N/A
- EPS Growth
- TLSA N/A
- ANVS N/A
- EPS
- TLSA N/A
- ANVS N/A
- Revenue
- TLSA N/A
- ANVS N/A
- Revenue This Year
- TLSA N/A
- ANVS N/A
- Revenue Next Year
- TLSA N/A
- ANVS N/A
- P/E Ratio
- TLSA N/A
- ANVS N/A
- Revenue Growth
- TLSA N/A
- ANVS N/A
- 52 Week Low
- TLSA $0.41
- ANVS $4.53
- 52 Week High
- TLSA $1.74
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- TLSA 65.44
- ANVS 58.70
- Support Level
- TLSA $0.83
- ANVS $9.00
- Resistance Level
- TLSA $0.92
- ANVS $10.54
- Average True Range (ATR)
- TLSA 0.09
- ANVS 0.81
- MACD
- TLSA 0.03
- ANVS 0.12
- Stochastic Oscillator
- TLSA 84.52
- ANVS 74.57
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.